Q:

Which of the following is the first non-factor prophylactic bypassing agent that was recently approved for haemophilia A patients with and without inhibitors?

A) Tocilizumab B) Itolizumab
C) Hemilizumab D) Emicizumab
 

View Answer Explanation

30